This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
A

ESMO 2024 Insights: LBA51 DUART Trial - ctDNA Dynamics and Treatment Responses in CT-Ineligible Stage III NSCLC

By 2024 ESMO Annual Meeting Insights Hub FEATURING Andrea Filippi
By 2024 ESMO Annual Meeting Insights Hub FEATURING Andrea Filippi
3 views
October 11, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

2024 ESMO Annual Meeting Insights Hub: Lung Videos

08:49
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

Feat. K. Natsuhara
05:10
ecancer

ESMO 2024 Insights: PIONeeR Trial - IO Resistance Pathways Investiga…

Feat. P. Tomasini
19:15
ecancer

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON…

Feat. I. Gil-Bazo, M. Brandão, B. Besse, E. Felip
View All

Related Content

AUTOPLAY
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
35:40
Balazs Halmos

Year in Review: Lung Cancer

18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
11:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…

Feat. J. West
17:05
MI&T Congressi

Mediastinal Staging of Lung Cancer

Feat. R. Trisolini
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
16:12
Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon
14:49
Vivek Subbiah

Year in Review: Precision Medicine

19:33
ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

Feat. E. Felip, A. Spira, A. Passaro, A. Addeo
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
28:32
West Virginia State Rheumatology Society

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Feat. J. Bustamante
09:37
Luis Raez

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

09:40
John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
15:09
Oncology Data Advisor

World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Feat. S. Kareff, B. Sandy, M. Vojnic
08:18
MI&T Congressi

ADC in Combination With Immunotherapy for NSCLC

Feat. S. Liu